Why You Should Learn the Playbook: Know the Game Plan for Distressed Acquisitions and Divestitures, Part Four—Regulatory Compliance and Related Issues in Distressed Health Care Transactions
This Briefing is brought to you by AHLA’s Business Law and Governance Practice Group.
- May 29, 2025
- Jessica Scouten , PYA, PC
- Megan Preusker , Mintz Levin Cohn Ferris Glovsky & Popeo PC
- Ryan K. Cochran , Epstein Becker & Green PC
As health care practitioners know, health care transaction notice and review laws have been on the rise. In general, bankruptcy and receivership proceedings do not circumvent or even shortcut state or federal regulatory requirements for health care transactions, including with respect to licensure and change of ownership. Insolvency practitioners typically work with their health care counterparts to understand the applicable regulatory notice and approval requirements, processes, and timelines. However, there are certain unique considerations underlying the regulatory approval process in a distressed health care transaction.
ARTICLE TAGS
You must be logged in to access this content.